JONATHAN MACQUITTY

Profile

First Name

: JONATHAN

Middle Name

:

Last Name

: MACQUITTY

Related Companies
Titles
Company Name
Related People
DIRECTOR
DICERNA PHARMACEUTICALS INC
DOUGLAS FAMBROUGH, BRIAN K. HALAK, STEPHEN HOFFMAN, JAMES C. JENSON, PETER KOLCHINSKY, DENNIS LANGER, DENNIS H. LANGER, DAVID MADDEN
DIRECTOR
GYNESONICS, INC
JORDAN BAJOR, LOUIS BALDINO, ROBERT BROWN, MIKE CARUSI, JOYCE ERONY, DOUG FISHER, LINDA GRAIS, GREG GREIFELD, KEN HAAS, HUGO HARROD, CHANDRA LEO, CHANDRA P. LEO, JONATHAN MCQUITTY, DAVID NEUSTAEDTER, ROBERT O-HOLLA, ROBERT H. O-HOLLA, CHRISTOPHER OWENS, CHRISTOPHER M. OWENS, DAVID PACITTI, TOM RODGERS, ALEXANDER SCHMITZ, JEFFREY SCHWARTZ, SUSAN STIMSON, KAREN TALMADGE, DARRIN UECKER
DIRECTOR
PERSONALIS, INC.
PATRICK BALTHROP, ANDREW CHUNG, JON FEIBER, KEN LUDLUM, VINCENT MILES, CHRIS SCHAEPE, SUE SIEGEL, CAROL TILLIS, JOHN WEST
DIRECTOR
LABCYTE INC
TAMMY CAMERON, TAMMY L. CAMERON, RICHARD ELLSON, MARK FISCHER-COLBRIE, ELAINE J. HERON, JOE KEEGAN, JOSEPH D. KEEGAN, ANDRE MARION, SANDRA PANEM, JOSEPH SMITH, JOSEPH H. SMITH, CRAIG TAYLOR, CRAIG C. TAYLOR
DIRECTOR
PALO ALTO HEALTH SCIENCES, INC.
STEPHEN BRUSO, JOSEPH PEREKUPKA, AMY PERRY, DEBRA REISENTHEL, DEAN SAWYER, EDWIN F. SCHEETZ, NED SCHEETZ, STEVE SCHWARTZ, EDWIN SHEETZ, ELIZABETH SIEGELMAN, RUSSELL SIEGELMAN, SIMON THOMAS
DIRECTOR, EXECUTIVE OFFICER
FORTY SEVEN, INC.
JEFFREY BIRD, DENNIS HENNER, ERIC JENSEN, RAVINDRA MAJETI, MARK A. MCCAMISH, CHRIS SCHAEPE, CHRISTOPHER SCHAEPE, IRVING WEISSMAN
EXECUTIVE OFFICER, DIRECTOR
D2G ONCOLOGY, INC.
KATHLEEN D. LAPORTE, KATHY LAPORTE, DMITRI PETROV, MONTE WINSLOW
DIRECTOR
ORCA BIOSYSTEMS INC
IVAN DIMOV, NATHANIEL FERNHOFF, ALEX KOLICICH
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-07-09
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-29 
2020-04-27
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-12 
2020-02-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-12 
2017-10-31
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-17 
2017-07-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-06-29 
2017-03-01
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-17 
2016-03-04
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-27 
2016-03-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-23 
2015-09-02
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-27 
2015-04-22
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2015-04-09 
2014-12-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-16 
2014-07-09
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2013-02-08 
2013-10-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-01 
2013-09-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-21 
2013-08-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-30 
2013-02-21
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2013-02-08 
2013-01-24
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2013-01-16 
2013-01-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-21 
2012-12-07
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2012-12-05 
2012-02-22
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2012-02-08 
2011-08-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-04 
2010-10-29
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2010-10-15 
2010-10-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-08-05 
2010-08-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-08-05 
2010-06-28
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2010-06-17